Stroynost Plus (Drops) Instructions for Use
Marketing Authorization Holder
Mercana Service, LLC (Russia)
Manufactured By
Kurortmedservis, LLC (Russia)
Or Manufactured By
PLUTON-PHARM, JSC (Russia)
Dosage Form
| Stroynost Plus | Oral drops: bottle 25 ml, 50 ml, or 100 ml |
Dosage Form, Packaging, and Product Composition
| Oral drops | 100 ml |
| Biologically active components, not less than | |
| Arbutin | 40 mg |
| Caffeine | 5 mg |
Composition concentrated extract of a herbal complex (birch buds and leaves, burdock root, corn silk, marsh cudweed herb, field horsetail herb, cowberry leaf, common rowan berries), Caffeine, ascorbic acid, water.
25 ml – bottles with a dropper or mechanical dispenser.
50 ml – bottles with a dropper or mechanical dispenser.
100 ml – bottles with a dropper or mechanical dispenser.
Properties
Dietary supplement. The effect is due to the properties of the components included in the product.
It has an anorectic effect (reduces the feeling of hunger), helps to normalize lipid and carbohydrate metabolism, reduces the risk of atherosclerosis, increases vitality, psycho-emotional activity and performance.
It contributes to a comfortable well-being while following a low-calorie diet.
The components included in the product have anti-sclerotic, hypoglycemic, anti-inflammatory, detoxifying, choleretic, diuretic and general strengthening effects.
Scope of Application
As an auxiliary agent for body weight control in people suffering from obesity, atherosclerosis and type 2 diabetes mellitus.
Indications
- Use as an adjunctive therapy for body weight control in individuals with obesity.
- Employ as a supplementary measure for patients with type 2 diabetes mellitus to assist in metabolic management.
- Utilize as an auxiliary agent in the comprehensive management of atherosclerosis.
This product is intended to support a reduced-calorie diet and should be used as part of a broader therapeutic regimen under medical supervision.
ICD codes
| ICD-10 code | Indication |
| E11 | Type 2 diabetes mellitus |
| E66 | Obesity |
| I70 | Atherosclerosis |
| ICD-11 code | Indication |
| 5A11 | Type 2 diabetes mellitus |
| 5B81.Z | Obesity, unspecified |
| BD40.Z | Atherosclerosis of peripheral arteries, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Determine the dosage regimen individually based on the specific clinical application and patient factors.
Consult the prescribing physician for the exact number of drops and frequency of administration. Adhere strictly to the prescribed daily dose.
Do not exceed the recommended duration of use without medical supervision. Use the provided dropper or mechanical dispenser for accurate dosing.
Adverse Reactions
Monitor for potential adverse reactions during therapy. Allergic reactions are possible, including skin rash, pruritus, and urticaria.
Due to the caffeine content, be aware of possible central nervous system effects such as agitation, anxiety, tremor, insomnia, palpitations, and tachycardia. Discontinue use immediately if any severe hypersensitivity reactions occur and seek medical attention.
Drug Interactions
Exercise caution due to potential interactions. The caffeine component may potentiate the effects of other central nervous system stimulants.
Concomitant use with monoamine oxidase inhibitors (MAOIs) may lead to hypertensive crises. May interact with anti-diabetic medications, potentially altering glycemic control.
Consult a healthcare professional before concurrent use with other herbal preparations, especially those with diuretic or stimulant properties.
Contraindications
- Do not use in cases of known hypersensitivity or allergy to any product component, including the herbal complex or caffeine.
- Contraindicated in patients with severe cardiovascular diseases, including uncontrolled hypertension, severe arrhythmias, or recent myocardial infarction.
- Avoid use in individuals with a history of seizures, severe anxiety disorders, or insomnia.
Not recommended during pregnancy and lactation. Use in children only with specialized pediatric formulations and under medical guidance.
Overdose
In case of suspected overdose, discontinue use immediately and seek urgent medical assistance. Symptoms of overdose may be primarily related to caffeine intoxication.
Manifestations can include severe restlessness, anxiety, tremor, palpitations, cardiac arrhythmias, nausea, vomiting, and in severe cases, seizures. Provide symptomatic and supportive care.
Inform medical personnel of all ingested substances. Do not induce vomiting unless directed by a poison control center or physician.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer